RMTI: Gunggung utang perusahaan Rockwell Medical

Simbol lan logo merek rockwellmed.com (RMTI)

Rockwell Medical, Inc. (RMTI) leads the production of CitraPure solutions, optimizing deliveries through its own logistics. Recurring demand from clinics allows for profit scaling amid stable costs. The total debt trajectory reflects the dynamics of expansion financing, where 0.01 represents the current metric. The humanitarian status of the products minimizes external risks, guaranteeing stable global sales in the future.

RMTI: Utang perusahaan Rockwell Medical 04.07.2022 - 31.10.2026

Rockwell Medical, Inc. (RMTI) - rincian metrik lan laporan keuangan

- rega saham lan konsensus proyeksi valuasi:
Bagan owah-owahan rega Rockwell Medical Inc.|RMTI - Prakiraan konsensus analis
- informasi kapitalisasi pasar:
Kapitalisasi pasar Rockwell Medical|RMTI - Nilai Total Perusahaan
- data ekuitas miturut neraca:
Nilai Akuntansi Saham Rockwell Medical|RMTI - Nilai Buku Perusahaan|Rasio Kapitalisasi marang Aset Bersih rockwellmed.com|RMTI - Total Aset Perusahaan
- indikator beban kredit lan likuiditas emiten:
Total Utang marang Modal Rockwell Medical, Inc.|RMTI - Rasio utang jangka dawa marang ekuitas|Rasio tanggungan utang jangka cendhak marang modal rockwellmed.com|RMTI - Utang perusahaan|Utang-utang marang kapitalisasi buku Rockwell Medical|RMTI - Utang jangka dawa perusahaan|Gunggunge utang jangka cendhak Rockwell Medical|Rasio likuiditas darurat rockwellmed.com
- informasi bathi lan kelipatan valuasi:
RMTI - Bathi resik perusahaan
Analisis fundamental perusahaan:RMTI Rockwell Medical Inc.
Produk mawa merek Rockwell Medical Inc.

As a manufacturer of critical hemodialysis concentrates, Rockwell Medical, Inc. (RMTI) relies on stable demand and predictable cash flow. The total amount of borrowed funds, reflected in the liabilities on this chart, measures the overall credit load, allowing investors to assess the balance between expansion and default risk. Moderate leverage combined with sustainable FCF confirms the fundamental reliability and financial stability of the business.

Perusahaan pesaing

TVTX (Travere Corp) - Kewajiban utang agregat|Gunggung utang perusahaan ARDX (Ardelyx, Inc.)|Gunggung utang perusahaan prokidney.com PROK|AKBA - Utang perusahaan|Kewajiban utang agregat TVRD (Cara Therapeutics, Inc.)|DiaMedica Pharma (DMAC) - Utang perusahaan|Gunggung utang perusahaan Unicycive Therapeutics, Inc|CVKD (Cadrenal Therapeutics) - Gunggung utang perusahaan|Gunggung utang perusahaan conduitpharma.com|Gunggung utang perusahaan CALT (Calliditas Therapeutics)|RNLX (Renalytix Plc) - Kewajiban utang agregat|Utang perusahaan ZyVersa Therapeutics, Inc. ZVSA